Good research practices for measuring drug costs in cost-effectiveness analyses: A managed care perspective: The ISPOR drug cost task force report - Part III

Edward C. Mansley, Norman V. Carroll, Kristina S. Chen, Nilay D. Shah, Catherine Tak Piech, Joel W. Hay, James Smeeding

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Good research practices for measuring drug costs in cost-effectiveness analyses: A managed care perspective: The ISPOR drug cost task force report - Part III'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences